查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198491

無菌過濾市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Sterile Filtration Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

無菌過濾市場預計在預測期內的複合年增長率為 8%。

滅菌或過濾可去除細菌、真菌、病毒和原生動物等微生物，這些微生物會污染藥物、疫苗或替代品、化學品、食品或其他產品並構成健康風險。至關重要的是，COVID-19 大流行已經對市場產生重大影響。 在大流行期間，對 COVID-19 疫苗和療法的需求不斷增長推動了無菌過濾市場。 根據 2021 年 5 月發表在 Computational and Structural Biotechnology Journal 上的一篇論文，有 184 種候選疫苗處於臨床前研究階段，88 種處於臨床試驗階段。 無菌過濾是回收 COVID-19 候選疫苗的無菌過程中的關鍵步驟，因為它支持高選擇性和有效的候選疫苗。 因此，COVID-19 增加了對無菌過濾技術的需求，並且由於無菌過濾是藥物製劑開發的關鍵步驟之一，預計在預測期內將繼續保持同樣的趨勢。

慢性病的增加以及製藥和生物製藥行業的增長推動了市場的發展。 慢性病包括癌症、心血管疾病、神經系統疾病等，有望推動市場增長。 根據美國癌症協會 2021 年的報告，2021 年美國將有約 190 萬癌症患者（970,250 名男性和 927,910 名女性）被診斷出患有癌症，並有 608,570 名美國人死於 因此，慢性病的高負擔和生命科學研究與開發的高投資有望推動市場增長。

生物技術和製藥公司為擴大產品線和一次性技術的地理覆蓋範圍而增加的支出預計將增加對無菌過濾的需求，從而促進分析市場的增長。 例如，2021 年 7 月，Cytiva 和 Pall 公司宣布，他們將在未來兩年內投資 15 億美元，以滿足對生物技術解決方案日益增長的需求，包括生物反應器和一次性過濾器等一次性技術。將分配超過3 億美元用於擴大其在美國和英國的業務。

因此，預計上述因素等因素將在預測期內提振市場。 然而，無菌過濾的高成本可能會抑制市場增長。

除菌過濾的市場趨勢

預計濾芯過濾器市場將出現顯著增長

濾筒式過濾器因其高納污能力、長壽命、成本效益、可靠性和卓越性能而有望增長。 筒式過濾器是管式過濾裝置，用於各種行業的過濾，從高純水的預過濾到最終產品加工再到化學過濾。 它也廣泛用於廢水處理，因為它甚至對微量污染物也有效。

生物製藥和製藥公司大幅推高了研發成本。 根據美國國會預算辦公室2021年公佈的數據，醫藥領域的研發支出預計將從2019年的8300萬美元增長到2020年的2000多億美元。 因此，公司增加研發投資將增強公司採用創新技術和過濾系統的能力，從而促進市場增長。

此外，主要參與者不斷增加的技術開發、產品批准和合作夥伴關係將有助於擴大市場。 例如，2021 年 10 月，派克漢尼汾公司的工業氣體過濾和發電部門推出了兩款新的售後濾筒。 這些過濾器專為專業應用而設計，可幫助客戶提高利潤。 這些產品的推出預計將增加對筒式過濾器的需求，從而推動該領域的增長。

因此，上述因素有望在預測期內推動該行業的增長。

北美將在市場中佔有重要地位，預計在預測期內也會如此

由於研發支出增加和無菌過濾器技術不斷進步等因素，預計北美將在膜過濾器領域佔據很大份額。 多家製藥公司和政府機構最近增加了研發支出，預計這將在預測期內推動市場增長。 例如，根據3M Company Annual Report-2021，2021年將投入19.94億美元用於研發，而2020年為18.78億美元。 丹納赫公司在 2021 年的研發投資為 17.42 億美元，而 2020 年為 13.48 億美元。 預計這將增加過濾系統中新技術的採用，從而提供更高的準確性並減少污染參數，從而刺激市場的增長。

主要市場進入者的出現和產品開發的先進技術有望在該領域確立主導地位。 例如，2021 年 10 月，美國國家生物製藥製造創新研究所 (NIIMBL) 批准了 300 萬美元的撥款，用於六台新的生物製藥製造設備。 北卡羅來納州立大學、馬薩諸塞大學、佐治亞大學、密歇根大學、特拉華大學、卡內基梅隆大學和其他大學將獲得資助。 預計按地區增加研發投資將推動市場增長。

薄膜過濾器和相關過濾系統的新產品發布預計將在預測期內推動該地區的市場增長。 例如，2021 年 11 月，杜邦水務解決方案 (DWS) 宣布推出 TapTec LC HF-4040，這是一種結合了高流量和可靠性的反滲透膜過濾器，適用於商業建築。

無菌過濾市場競爭對手分析

由於全球和本地參與者的存在，無菌過濾器市場競爭適中。 隨著無菌過濾器的使用越來越多，少數中小型公司有望進入市場，並有望在未來佔據相當大的份額。 無菌過濾器市場上的知名公司有 Danaher Corporation、Merck KGaA、ThermoFisher Scientific Inc.、Sartorius AG、GE Healthcare、3M、Cole-Parmer Instrument Company, LLC、Sterlitech Corporation、Eaton Corporation、Porvair Filtration Group 等。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 增加慢性病負擔
    • 製藥和生物製藥行業的發展
  • 市場製約因素
    • 無菌過濾成本高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品分類
    • 筒式過濾器
    • 膠囊過濾器
    • 注射器過濾器
    • 其他膜過濾器
    • 配飾
  • 最終用戶
    • 製藥和生物技術公司
    • 委託研究機構
    • 研究所
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • 3M
    • Cole-Parmer Instrument Company, LLC
    • Danaher Corporation
    • Eaton Corporation
    • GE Healthcare
    • Merck KGaA
    • Sartorius AG
    • Porvair Filtration Group
    • Sterlitech Corporation
    • ThermoFisher Scientific Inc.
    • Prominent GmbH
    • Koch Membrane Systems Inc.

第7章 市場機會今後動向

簡介目錄
Product Code: 70529

The sterile filtration market is expected to register a CAGR of 8% over the forecast period.

The global spread of COVID-19 had a significant impact on the market because sterilization or filtration is critical for the removal of microbes, such as bacteria, fungi, viruses, and protozoa, that may contaminate medicinal drugs, vaccines, or alternative substances, chemicals, food, and other products, posing health risks. The growing demand for COVID-19 vaccines and treatment medications propelled the sterile filtration market during the pandemic. According to an article published in the Computational and Structural Biotechnology Journal in May 2021, there were 184 vaccine candidates in preclinical research and 88 under clinical trials. The sterile filtering method is an important step in the aseptic process for recovering COVID-19 vaccine candidates since it supports high selectivity and effective vaccine candidates. Thus, COVID-19 enhanced the demand for sterile filtration techniques and is expected to follow the same trend over the forecast period, as sterile filtration is one of the important procedures in drug formulation development.

The market is driven by the rising prevalence of chronic diseases and the the growing pharmaceutical and biopharmaceutical industries. Chronic diseases include cancer, cardiovascular, neurological and others diseases, and are expected to propel the growth of the market. According to the American Cancer Society's 2021 report, about 1.9 million cancer cases (970,250 in males and 927,910 in females) were diagnosed in 2021 in the United States, and 608,570 Americans died from it. Thus, the high burden of chronic diseases and high investments in life science research and development are expected to drive market growth.

With increasing expenditures by biotechnology and pharmaceutical businesses in expanding their product lines and geographical reach in single-use technologies, the need for sterile filtration is predicted to increase, bolstering the growth of the analyzed market. For instance, in July 2021, Cytiva and Pall Corporation revealed a USD 1.5 billion investment over the next two years to meet the rising demand for biotechnology solutions, with over USD 300 millionallocated for single-use technologies, such as bioreactor and single-use filters, to expand operations in the United States and the United Kingdom.

Thus, all the above-mentioned factors are expected to boost the market over the forecast period. However, the high cost of sterile filtration may restrain market growth.

Sterile Filtration Market Trends

Cartridge Filter Segment Expected to Exhibit Significant Market Growth

Cartridge filters are expected to grow because of their high dirt-holding capacity, extended service life, cost-effectiveness, reliability, and good performance. Cartridge filters are tubular filtration equipment used in various industries for filtration, ranging from pre-filtering high-purity water to final product processing and chemical filtration. They are widely used in wastewater treatment as they are effective against small contaminants.

Biopharmaceutical and pharmaceutical companies boost their research and development spending significantly. According to the data published by the Congressional Budget Office in 2021, pharmaceutical sectors were expected to spend over USD 200 billion on research and development in 2020, up from USD 83 million in 2019. Thus, increased investments in research and development by corporations boost the company's ability to adopt innovative technologies and filtration systems, hence improving market growth.

Furthermore, technological developments and increased product approvals, as well as partnerships by key players, assist market expansion. For instance, in October 2021, the Industrial Gas Filtration and Generation Division of Parker Hannifin Corporation launched two new aftermarket cartridge filters. These filters are designed to meet special applications to help customers improve their bottom line. These launches are expected to increase the demand for cartridge filters, hence boosting the growth of the segment.

Thus, the aforementioned factors are expected to boost the growth of segment over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant share of the market in the membrane filters segment due to factors such as rising research and development expenditure and increasing technological advancements in sterile filters. Various pharmaceutical businesses and government organizations recently increased their R&D spending, which is expected to boost market growth throughout the forecast period. For instance, as per the annual reports-2021 of 3M Company, in 2021, it invested USD 1.994 billion in research and development, compared to USD 1.878 billion in 2020. Danaher Corporation invested USD 1,742 million in its research and development in 2021, compared to USD 1,348 million in 2020. This is expected to increase the adoption of new technologies in filtration systems, which provide better accuracy and reduce fouling parameters, thereby fueling the market growth.

The presence of key market participants and advanced technology for product development are expected to establish the dominance of this area. For instance, in October 2021, the United States National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) approved a USD 3 million grant for six new biopharmaceutical manufacturing devices. North Carolina State University, the University of Massachusetts, the University of Georgia, the University of Michigan, the University of Delaware, and Carnegie Mellon University are among the institutions that will receive funding. The increase in regional R&D investments is expected to boost market growth.

New product launches of membrane filters and related filtering systems are likely to fuel market growth over the forecast period in the region. For instance, in November 2021, DuPont Water Solutions (DWS) introduced the TapTec LC HF-4040 reverse osmosis membrane filter, which is meant to combine high flow rates with reliability to be used in commercial buildings.

Sterile Filtration Market Competitor Analysis

The market for sterile filters is moderately competitive with the presence of global and local companies. With the rising use of sterile filters, few small to mid-sized companies are expected to enter the market and are believed to gain substantial shares in the future. The well-known companies in the sterile filtration market are Danaher Corporation, Merck KGaA, ThermoFisher Scientific Inc., Sartorius AG, GE Healthcare, 3M, Cole-Parmer Instrument Company, LLC, Sterlitech Corporation, Eaton Corporation, and Porvair Filtration Group.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases
    • 4.2.2 Growing Pharmaceutical and Biopharmaceutical Industries
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Sterile Filtration
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Cartridge Filter
    • 5.1.2 Capsule Filter
    • 5.1.3 Syringe Filter
    • 5.1.4 Other Membrane Filters
    • 5.1.5 Accessories
  • 5.2 By End User
    • 5.2.1 Pharmaceutical and Biopharmaceutical Companies
    • 5.2.2 Contract Research Organization
    • 5.2.3 Research Laboratories
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Cole-Parmer Instrument Company, LLC
    • 6.1.3 Danaher Corporation
    • 6.1.4 Eaton Corporation
    • 6.1.5 GE Healthcare
    • 6.1.6 Merck KGaA
    • 6.1.7 Sartorius AG
    • 6.1.8 Porvair Filtration Group
    • 6.1.9 Sterlitech Corporation
    • 6.1.10 ThermoFisher Scientific Inc.
    • 6.1.11 Prominent GmbH
    • 6.1.12 Koch Membrane Systems Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS